Mirum Pharmaceuticals, Inc. (MIRM) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$35.60M*; Operating income -$42.54M; Depreciation and amortization $6.94M*.
- 2026-03-31: Basis Reported; EBITDA -$782.59M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA $1.51M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA $8.66M*; Operating income $2.60M; Depreciation and amortization $6.06M*.
Complete source-backed ebitda history.
- Available history
- 2019-03-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$35.60M* | -$42.54M | $6.94M* | $176.24M | -20.20%* | $23.00K* | -$44.25M* | (m) | (m) | $81.47M | $1.69M |
|---|
| 2026-03-31 | Reported | -$782.59M | (m) | (m) | (m) | -489.48% | $664.00K | -$228.76M | (m) | (m) | $96.33M | $475.00K |
|---|
| 2025-12-31 | Reported | $1.51M | (m) | (m) | (m) | 1.01% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | $8.66M* | $2.60M | $6.06M* | $133.01M | 6.51%* | $187.00K* | $39.68M* | (m) | (m) | $61.91M | -$262.00K |
|---|
| 2025-06-30 | Reported | $1.07M* | -$4.99M | $6.06M* | $127.78M | 0.83%* | $126.00K* | $12.04M* | (m) | (m) | $63.29M | $402.00K |
|---|
| 2025-03-31 | Reported | -$9.13M | (m) | (m) | (m) | -8.18% | $41.00K | -$1.96M | (m) | (m) | $57.71M | $1.03M |
|---|
| 2024-12-31 | Reported | -$18.17M | (m) | (m) | (m) | -18.27% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$6.63M* | -$12.68M | $6.05M* | $90.38M | -7.33%* | $181.00K* | $3.98M* | (m) | (m) | $50.55M | $347.00K |
|---|
| 2024-06-30 | Reported | -$18.38M* | -$24.23M | $5.85M* | $77.88M | -23.60%* | $779.00K* | -$3.80M* | (m) | (m) | $49.21M | $635.00K |
|---|
| 2024-03-31 | Reported | -$20.8M | (m) | (m) | (m) | -30.05% | $13.00K | $15.21M | (m) | (m) | $45.64M | $624.00K |
|---|
| 2023-12-31 | Reported | -$27.09M | (m) | (m) | (m) | -38.95% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$22.49M* | -$25.15M | $2.66M* | $47.73M | -47.12%* | $0.00* | -$18.22M* | (m) | (m) | $36.53M | $249.00K |
|---|
| 2023-06-30 | Reported | -$22.94M* | -$24.27M | $1.34M* | $37.50M | -61.17%* | $68.00K* | -$17.33M* | (m) | (m) | $32.95M | $316.00K |
|---|
| 2023-03-31 | Reported | -$25.81M | (m) | (m) | (m) | -81.69% | $41.00K | -$18.77M | (m) | (m) | $30.22M | $201.00K |
|---|
| 2022-12-31 | Reported | -$32.96M | (m) | (m) | (m) | -118.11% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-09-30 | Reported | -$31.79M* | -$32.88M | $1.10M* | $18.78M | -169.25%* | $19.00K* | -$26.02M* | (m) | (m) | $22.51M | $13.00K |
|---|
| 2022-06-30 | Reported | -$30.84M* | -$31.44M | $599.00K* | $17.48M | -176.40%* | $17.00K* | -$20.17M* | (m) | (m) | $20.97M | -$6.57M |
|---|
| 2022-03-31 | Reported | -$32.39M | (m) | (m) | (m) | -251.27% | $0.00 | -$39.67M | (m) | (m) | $19.12M | $11.00K |
|---|
| 2021-12-31 | Reported | -$45.23M | (m) | (m) | (m) | -1441.46% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-09-30 | Reported | -$42.74M* | -$42.82M | $84.00K* | $5.00M | -854.80%* | $18.00K* | -$34.20M* | (m) | (m) | $17.35M | $9.00K |
|---|
| 2021-06-30 | Reported | -$37.32M* | -$37.40M | $79.00K* | $11.00M | -339.29%* | $0.00* | -$40.20M* | (m) | (m) | $13.35M | $11.00K |
|---|
| 2021-03-31 | Reported | -$47.52M | (m) | (m) | (m) | (m) | $3.00K | -$25.21M | (m) | (m) | $9.48M | $5.00K |
|---|
| 2020-12-31 | Reported | -$36.87M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-09-30 | Reported | -$21.64M* | -$21.72M | $77.00K* | $0.00 | (m) | $46.00K* | -$17.45M* | (m) | (m) | (m) | -$3.00K |
|---|
| 2020-06-30 | Reported | -$23.53M* | -$23.60M | $70.00K* | $0.00 | (m) | $53.00K* | -$16.99M* | (m) | (m) | (m) | $3.00K |
|---|
| 2020-03-31 | Reported | -$21.96M | (m) | (m) | (m) | (m) | $98.00K | -$18.35M | (m) | (m) | (m) | $4.00K |
|---|
| 2019-12-31 | Reported | -$18.6M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2019-09-30 | Reported | -$15.83M* | -$15.87M | $37.00K* | (m) | (m) | $170.00K* | -$15.22M* | (m) | $12.16M | (m) | $0.00 |
|---|
| 2019-06-30 | Reported | -$13.99M* | -$14.03M | $43.00K* | (m) | (m) | $0.00* | -$8.02M* | (m) | $11.59M | (m) | $0.00 |
|---|
| 2019-03-31 | Reported | -$6.18M | (m) | (m) | (m) | (m) | $44.00K | -$2.43M | (m) | (m) | (m) | $0.00 |
|---|
| 2018-09-30 | Reported | (m) | -$65.00K | (m) | (m) | (m) | (m) | (m) | (m) | $3.00K | (m) | $0.00 |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | $2.11M | (m) | (m) | (m) | 0.40% | $954.00K | $55.83M | (m) | (m) | $257.03M | $1.94M |
|---|
| 2024-12-31 | Reported | -$63.98M | (m) | (m) | (m) | -18.99% | $993.00K | $10.32M | (m) | (m) | $202.22M | $1.03M |
|---|
| 2023-12-31 | Reported | -$98.33M | (m) | (m) | (m) | -52.76% | $109.00K | -$70.94M | (m) | (m) | $145.88M | $991.00K |
|---|
| 2022-12-31 | Reported | -$127.98M | (m) | (m) | (m) | -166.08% | $278.00K | -$120.14M | (m) | (m) | $89.07M | -$6.41M |
|---|
| 2021-12-31 | Reported | -$172.82M | (m) | (m) | (m) | -903.01% | $24.00K | -$132.76M | (m) | (m) | $59.22M | $37.00K |
|---|
| 2020-12-31 | Reported | -$103.99M | (m) | (m) | (m) | (m) | $225.00K | -$89.08M | (m) | (m) | (m) | $6.00K |
|---|
| 2019-12-31 | Reported | -$54.6M | (m) | (m) | (m) | (m) | $281.00K | -$39.36M | (m) | (m) | (m) | $21.00K |
|---|